Chlamydia pneumoniae Seropositivity in the Iranian Patients with the Skin Inflammatory Disorder of Rosacea

被引:0
|
作者
Aghaei, Maryam [1 ]
Aghaei, Shahrzad [2 ]
Nilforoushzadeh, Mohammad-Ali [3 ]
Abdellahi, Latifeh [1 ,4 ]
Naeini, Farahnaz Fatemi [4 ]
Iraji, Fariba
Hosseini, Sayed Mohsen [5 ]
Hejazi, Seyed Hossein [6 ]
机构
[1] Isfahan Univ Med Sci, Skin Dis & Leishmaniasis Res Ctr, Esfahan, Iran
[2] Shahrekord Univ Med Sci, Sch Adv Technol, Dept Mol Med, Shahrekord, Iran
[3] Univ Tehran Med Sci, Skin & Stem Cell Res Ctr, Tehran, Iran
[4] Isfahan Univ Med Sci, Sch Med, Dept Dermatol, Skin Dis & Leishmaniasis Res Ctr, Esfahan, Iran
[5] Isfahan Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Esfahan, Iran
[6] Isfahan Univ Med Sci, Sch Med, Dept Parasitol & Mycol, Skin Dis & Leishmaniasis Res Ctr, Esfahan, Iran
来源
ADVANCED BIOMEDICAL RESEARCH | 2023年 / 12卷 / 01期
关键词
Chlamydia pneumonia; ELISA; IgG; IgM; rosacea; seropositivity; DISEASES; RISK;
D O I
10.4103/abr.abr_233_21
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Rosacea is a skin chronic inflammation with an unknown cause and cure. Environmental and genetic factors could not entirely explain the disease pathogenesis. Recently, infections like Chlamydia pneumoniae are of more attention in the rosacea progression. This study investigated the relationship between the C. pneumoniae seropositivity and the rosacea disorder. Materials and Methods: We aimed at a cohort of 100 patients with the rosacea disorder (60 active and 40 inactive) and from 100 sex- and age-matched healthy controls in Isfahan and determined the immunoglobulin M (IgM)/IgG antibodies titers to C. pneumoniae in the serum using the enzyme-linked immunosorbent assay method. The groups were compared using the analysis of variance procedure at the significant level of P < 0.05, statistically. Results: The mean of IgG in the controls was significantly higher than the levels in both the active and the inactive rosacea patients (p < 0.022). Also, the titer of serum IgM to C. pneumoniae in the controls was different, compared with the active (p < 0.019) and the inactive (p < 0.02) rosacea patients. In addition, the median titer of serum IgG (not IgM) to C. pneumoniae in the females with the inactive rosacea disorder was lower than the active rosacea disorder (p < 0.019) and controls women (p < 0.008). Furthermore, the serum level of IgG or IgM to C. pneumoniae in the controls males was higher than the males with the rosacea disorder (p < 0.05) and (p < 0.02), alternatively. Conclusion: C. pneumoniae seropositivity in the rosacea patients and controls was insignificant.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study
    Aghaei, Maryam
    Ashtari, Fereshteh
    Bahar, Mohammadali
    Falahian, Mohammad Reza
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2011, 45 (02) : 128 - 131
  • [2] Chlamydia pneumoniae seropositivity and hyperhomocysteinemia are linked in patients with atherosclerosis
    Wiesli, P
    Maly, FE
    Meniconi, A
    Czerwenka, W
    Hoffmann, U
    Vetter, W
    Schulthess, G
    [J]. CLINICAL CHEMISTRY, 2001, 47 (07) : 1304 - 1306
  • [3] Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis
    Romeo, F
    Martuscelli, E
    Chirieolo, G
    Cerabino, LM
    Ericson, K
    Saldeen, TGP
    Mehta, JL
    [J]. CLINICAL CARDIOLOGY, 2000, 23 (05) : 327 - 330
  • [4] Chlamydia pneumoniae seropositivity in Iranian multiple sclerosis: A randomized case-control study
    Ashtari, F.
    Aghaei, M.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (10): : 1279 - 1280
  • [5] Seropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Children
    Tutanc, Murat
    Gurkan, M. Fuat
    Yel, Servet
    Gunes, Ali
    Konca, Capan
    Bilen, Gulseren
    [J]. JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (03) : 353 - 357
  • [6] Detection of Chlamydia pneumoniae in atherosclerotic plaque of Iranian patients
    Eslami, G
    Fallah, F
    Eslami, M
    Botorabi, M
    Goudarzi, H
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 72 - 72
  • [7] Chlamydia pneumoniae seropositivity in relation to endothelial dysfunction in patients with ischemic stroke
    Devidze, E.
    Ninua, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 253 - 253
  • [8] IMPORTANCE OF SMOKING FOR CHLAMYDIA-PNEUMONIAE SEROPOSITIVITY
    KARVONEN, M
    TUOMILEHTO, J
    PITKANIEMI, J
    NAUKKARINEN, A
    SAIKKU, P
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1994, 23 (06) : 1315 - 1321
  • [9] Chlamydia Pneumoniae Seropositivity and Risk of Ischemic Stroke
    Bozkurt, Dilek
    Hiz, Fazilet
    Cinar, Meral
    Kok, Ferhan Fettahoglu
    [J]. JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2012, 2 (01): : 15 - 19
  • [10] Chlamydia pneumoniae seropositivity and the risk of NAION -: Reply
    Weger, M
    El-Shabrawi, Y
    Stanger, O
    Haas, A
    Haller-Schober, EM
    [J]. OPHTHALMOLOGY, 2003, 110 (06) : 1067 - 1067